Sana, Codexis lay off staff, reshuffle pipeline in bid to focus cell therapy, enzyme engineering work
As its market cap shrinks to a fraction of its heyday, flashy cell therapy startup Sana Biotechnology is laying off 15% of its staffers in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
